What are you looking for?
All Filters
Therapeutic Area
Therapeutic Area
Date Published
Date published

MAYZENT®


Indications


Mayzent is indicated for the treatment of adult patients with secondary progressive multiple sclerosis (SPMS) with active disease evidenced by relapses or imaging features of inflammatory activity.

Package Insert

Novartis Risk Management Plan (RMP) Educational Material for Patients
HSA Approved RMP – Patient and Caregiver Medication Guide

HSA Approved RMP

Patient and Caregiver Medication Guide

PDF
Download
HSA Approved RMP – Patient Pregnancy Guide

HSA Approved RMP

Patient Pregnancy Guide

PDF
Download
Novartis Risk Management Plan (RMP) Educational Material for Physicians
HSA Approved RMP – HCP Checklist

HSA Approved RMP

HCP Checklist

PDF
Download